We normally keep a gimlet eye on the ASX director buying and selling. But back in October, we were rather surprised to discover that the chief of biotech PolyNovo had managed to dispose of 722,155 shares in the company over the preceding financial year, all without us (or anyone else) noticing.
Paul Brennan, while happy to discuss his sales, was under no obligation to disclose them, because he didn't technically sit on PolyNovo's board.
Loading...
Myriam Robin is Rear Window editor based in the Melbourne newsroom. A Rear Window columnist since 2017, she previously reported on financial markets and media. Connect with Myriam on Twitter. Email Myriam at myriam.robin@afr.com
